Sorohan, B.M.; Sinescu, I.; Tacu, D.; Bucșa, C.; Țincu, C.; Obrișcă, B.; Berechet, A.; Constantinescu, I.; Mărunțelu, I.; Ismail, G.;
et al. Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation. J. Clin. Med. 2021, 10, 5390.
https://doi.org/10.3390/jcm10225390
AMA Style
Sorohan BM, Sinescu I, Tacu D, Bucșa C, Țincu C, Obrișcă B, Berechet A, Constantinescu I, Mărunțelu I, Ismail G,
et al. Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation. Journal of Clinical Medicine. 2021; 10(22):5390.
https://doi.org/10.3390/jcm10225390
Chicago/Turabian Style
Sorohan, Bogdan Marian, Ioanel Sinescu, Dorina Tacu, Cristina Bucșa, Corina Țincu, Bogdan Obrișcă, Andreea Berechet, Ileana Constantinescu, Ion Mărunțelu, Gener Ismail,
and et al. 2021. "Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation" Journal of Clinical Medicine 10, no. 22: 5390.
https://doi.org/10.3390/jcm10225390
APA Style
Sorohan, B. M., Sinescu, I., Tacu, D., Bucșa, C., Țincu, C., Obrișcă, B., Berechet, A., Constantinescu, I., Mărunțelu, I., Ismail, G., & Baston, C.
(2021). Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation. Journal of Clinical Medicine, 10(22), 5390.
https://doi.org/10.3390/jcm10225390
